Business Wire

Lattice Sentry Solutions Stack and SupplyGuard Service Deliver End-to-End Supply Chain Protection with Dynamic Trust

Share

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today launched the Lattice Sentry™ solutions stack and the Lattice SupplyGuard™ supply chain protection service. The Sentry stack is a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193). The Lattice SupplyGuard service extends the system protection provided by the Sentry stack throughout today’s challenging and rapidly changing supply chain by delivering factory-locked devices to protect them from attacks like cloning and malware insertion, and enables secure device ownership transfer. These hardware security solutions are increasingly important to a range of applications, including communications, datacenter, industrial, automotive, aerospace, and client computing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005214/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Lattice Sentry Solutions Stack (Graphic: Business Wire)

According to Patrick Moorhead, president and founder of Moor Insights & Strategy, “5G, Edge computing, and IoT are accelerating the pace at which devices are becoming connected, and security concerns are on the rise among high-tech OEMs serving every market. Developers need to know their hardware platforms are secured against cyberattack and IP theft. They need security solutions that support comprehensive protection throughout a product’s entire operating life in the field, which means the solution must be able to dynamically adapt to an evolving threat landscape.”

“Lattice continues to execute to our solutions stack roadmap and strategy to provide our customers with easy to use, system-level solutions for key focus applications. The Lattice Sentry solutions stack makes it easy for customers to implement a hardware Root-of-Trust (RoT)-based PFR solution compliant with the NIST SP-800-193 guidelines,” said Deepak Boppana, Sr. Director, Segments and Solutions Marketing, Lattice. “With Sentry’s validated IPs, pre-verified reference designs, and hardware demos, developers can quickly customize the PFR solution by modifying the C code provided with the RISC-V and Propel design environment to cut time-to-market from ten months to just six weeks.”

The security paradigm is changing, and firmware is an increasingly popular attack vector. The National Vulnerability Database reported that between 2016 and 2019 the number of firmware vulnerabilities grew over 700 percent1. Protecting systems against unauthorized firmware access requires dynamic, persistent, real-time hardware platform security for all connected devices. This includes securing component firmware from unauthorized access and enabling the system to automatically protect, detect, and recover from an attack in an instant. TPM and MCU-based hardware security solutions use serial processing and cannot deliver the real-time performance that parallel processing solutions like Lattice FPGAs can.

“To provide them with peace of mind in a constantly changing and increasingly risky supply chain environment, Lattice developed our SupplyGuard service to help our customers securely provision their devices while lowering their overall costs,” said Eric Sivertson, Vice President of Security Business, Lattice. “With Sentry and SupplyGuard, Lattice delivers comprehensive, truly parallel, nanosecond reactive, next-generation security to enable dynamic trust for our customers and the users of their products.”

Key features of the Lattice Sentry solutions stack include:

  • Hardware security capabilities – the Sentry solutions stack provides a pre-verified, NIST-compliant PFR implementation that enforces strict, real-time access controls to all system firmware during and after system boot. If corrupt firmware is detected, Sentry can automatically rollback to a previously known good state version of the firmware so secure system operation continues without interruption.
  • Compliance with latest NIST SP-800-193 standard and CAVP certifications – the stack enables implementation of a hardware RoT through its support for the cryptographically-sound Lattice MachXO3D™ family of FPGAs.
  • Ease of use – developers can drag-and-drop Sentry’s validated IPs and modify the included RISC-V C reference code in the Lattice Propel design environment without any prior FPGA experience.
  • Rapid time-to-market – the Sentry stack provides pre-verified and tested application demos, reference designs, and development boards that can slash development times for PFR applications from ten months to just six weeks.
  • Flexible, platform-agnostic security solution – Sentry offers comprehensive, real-time PFR support for firmware and programmable peripherals. It can act as a RoT in a system and/or complement any existing BMC/MCU/TPM-based architecture for full NIST SP-800-193 compliance.

Key features of the Lattice SupplyGuard supply chain protection service include:

  • Robust security throughout device lifecycle – SupplyGuard is a subscribed service that offers OEMs and ODMs peace of mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport through the global supply chain, system integration and assembly, initial configuration, and deployment. SupplyGuard helps protect OEMs by:
    • Ensuring only authorized manufacturers can build an OEM’s design, regardless of their location.
    • Providing OEMs with a secure key infrastructure to prevent the activation of their IP on unauthorized components to stop product cloning and overbuilding.
    • Securing devices against the download and installation of Trojans, malware, or other unauthorized software to protect platforms and systems against equipment hijacking or other cyberattacks.
  • Flexible, low-cost implementation – SupplyGuard is highly customizable to meet the specific security and supply chain needs of OEMs in every industry Lattice serves. The service lowers the operating costs associated with implementing a secure manufacturing ecosystem.

For more information, please visit www.latticesemi.com/LatticeSentry and www.latticesemi.com/LatticeSupplyGuard

About Lattice Semiconductor

Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.

For more information about Lattice, please visit www.latticesemi.com. You can also follow us via LinkedIn, Twitter, Facebook, YouTube, WeChat, Weibo or Youku.

Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.

GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.

1 Source: National Vulnerability Database (2016 and 2019)

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

MEDIA CONTACT:
Bob Nelson
Lattice Semiconductor
408-826-6339
Bob.Nelson@latticesemi.com

INVESTOR CONTACT:
Rick Muscha
Lattice Semiconductor
408-826-6000
Rick.Muscha@latticesemi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye